查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587572

全基因测序市场规模、份额、趋势分析报告：按产品/服务、按类型、按工作流程、按应用、按最终用途、按地区、细分市场预测，2025-2030

Whole Genome Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables, Services), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

全基因测序市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球全基因测序市场规模预计将达到66.7亿美元，2025年至2030年复合年增长率为22.17%。

市场成长的推动因素是基因组作图计画中越来越多地采用全基因测序以及遗传疾病（包括罕见遗传疾病）盛行率的增加。根据 2021 年 11 月发表在《新英格兰医学日誌》上的一项研究，全基因测序可能导致多种罕见疾病的早期诊断，报告了向精准医学的转变。

此外，增加对使用全基因组定序技术早期检测和治疗疾病的研发投资也有望推动市场成长。例如，2023年2月，印尼政府和基因组科学计画获得全球基金3,000万美元投资，用于支持对抗COVID-19、结核病、癌症、遗传疾病、脑部疾病和代谢性疾病等疾病我们建立了实施早期检测和治疗方法的设施网络。

全基因测序的应用范围广泛，政府机构正在采用这些技术对人类、植物、动物和微生物基因组序列测定，预计将推动市场成长。例如，美国食品药物管理局（FDA）在不同国家食源性疾病爆发期间就采用了这种方法来识别食源性病原体。 FDA 自 2008 年起在其全基因测序(WGS) 计画中采用了这项技术。这是因为它可以比脉衝场凝胶电泳 (PFGE) 更有效地识别所有食源性病原体菌株。

技术的不断进步催生了创新全基因测序产品的推出，这些产品可以经济、准确、及时地诊断各种疾病和感染疾病。这有助于市场的成长。例如，2022 年 12 月，LifeCell International Pvt. Ltd. 与 HaystackAnalytics 合作推出了 TB，这是一种全基因测序测试，旨在识别结核病感染的诊断资讯并应对抗药性挑战。

COVID-19 大流行增加了全球对该测试的需求，从而可以快速识别 SARS-CoV-2 并开发可能的诊断测试来控制疫情。因此，世界各国政府开始与研究机构和企业部门合作，利用这种方法来识别和诊断 SARS-CoV-2。几家公司已经宣布了用于监测 SARS-CoV-2 病毒的基因组服务和快速解决方案。例如，QIAGEN 为 SARS-CoV-2 监测提供全基因测序服务，以识别有效变异、追踪可能的疫情爆发并推进疫苗研究和药物开发。

全基因测序市场报告亮点

  • 消耗品细分市场在 2024 年占据最大份额，为 61.56%，原因是消耗品种类繁多，并且由于这些产品的保质期较短而采用率不断提高。
  • 从类型来看，大型全基因测序细分市场在2024年全基因测序市场中占最大份额，达到77.32%。这是由于癌症肿瘤分析和罕见疾病基因突变识别等应用的不断扩大。
  • 依工作流程划分，定序市场占最大市场占有率，2024年将达52.12%。这是由于领先公司的参与增加以及新产品的推出推动了该流程的采用。
  • 从应用来看，人类全基因测序领域在2024年占据市场主导地位，份额为62.91%。这是由于罕见遗传疾病的盛行率不断上升，以及为查明这些疾病的致病因素而增加的研发投资。
  • 依最终用途划分，学术和研究机构领域主导全球市场，份额最大，达 48.72%。该细分市场的很大一部分是由于这些设施对高通量技术的需求不断增加，以便在该领域进行全面的研究。
  • 北美地区占比最大，2024年为51.34%。这一巨大份额是由于该地区拥有成熟的医疗保健系统和製药行业，对用于临床和研究目的的全基因测序产生了巨大的需求。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 遗传疾病发生率增加
    • 降低基因序列分析的成本
    • 基因组作图程式对全基因组序列分析的需求不断增加
  • 市场限制因素分析
    • 与基因组定序相关的伦理和法律问题
  • 产业分析工具
    • 波特五力分析
    • 宏观经济分析
    • COVID-19 影响分析

第四章全基因测序市场：产品与服务的商业分析

  • 产品和服务细分仪表板
  • 全球全基因测序市场：产品与服务的变异分析
  • 2018-2030年全球全基因测序市场规模及产品与服务趋势分析
  • 装置
  • 消耗品
  • 服务

第五章全基因测序市场：类型业务分析

  • 类型细分仪表板
  • 全球全基因测序市场：类型变异分析
  • 2018-2030年全球全基因测序市场规模及趋势分析（按类型）
  • 大规模全基因组定序
  • 小规模全基因组定序

第六章全基因测序市场：工作流程业务分析

  • 工作流程细分仪表板
  • 全球全基因测序市场：工作流程变化分析
  • 2018-2030 年全球全基因测序市场规模及趋势分析（依工作流程）
  • 预测定序
  • 定序
  • 资料分析

第七章全基因测序市场：应用业务分析

  • 应用细分仪表板
  • 全球全基因测序市场：应用变异分析
  • 2018-2030年全球全基因测序市场规模及趋势分析（依应用）
  • 人类全基因组序列分析
  • 植物全EXOME定序
  • 动物全EXOME定序
  • 微生物全EXOME定序

第八章全基因测序市场：最终用途业务分析

  • 最终用途细分仪表板
  • 全球全基因测序市场：最终用途变异分析
  • 2018-2030 年全球全基因测序市场规模及趋势分析（依最终用途）
  • 学术研究所
  • 医院/诊所
  • 製药和生物技术公司
  • 其他的

第九章全基因测序市场：区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争格局

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 参与企业概况
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences of California, Inc.
    • BGI
    • QIAGEN
    • Agilent Technologies
    • ProPhase Labs, Inc.（Nebula Genomics）
    • Psomagen
    • Azenta US, Inc.（GENEWIZ）
Product Code: GVR-4-68040-037-0

Whole Genome Sequencing Market Growth & Trends:

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 22.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

Whole Genome Sequencing Market Report Highlights:

  • Consumables segment held the largest share of 61.56% in 2024, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
  • By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2024. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
  • By workflow, the sequencing segment held the largest market share of 52.12% in 2024, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
  • By application, the human whole genome sequencing segment dominated the market in 2024 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
  • By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
  • North America held the largest market share of 51.34% in 2024. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Workflow Segment
    • 1.2.4. Application Segment
    • 1.2.5. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Rising prevalence of inherited disorders
    • 3.2.2. Decreasing costs for genetic sequencing
    • 3.2.3. Rising demand for whole genome sequencing for genome mapping programs
  • 3.3. Market Restraint Analysis
    • 3.3.1. Ethical and legal challenges associated with genomic sequencing
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. Macroeconomic Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Whole Genome Sequencing Market: Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Whole Genome Sequencing Market: Product & Service Movement Analysis
  • 4.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Whole Genome Sequencing Market: Type Business Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Whole Genome Sequencing Market: Type Movement Analysis
  • 5.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Large Whole Genome Sequencing
    • 5.4.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 5.5. Small Whole Genome Sequencing
    • 5.5.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis

  • 6.1. Workflow Segment Dashboard
  • 6.2. Global Whole Genome Sequencing Market: Workflow Movement Analysis
  • 6.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 6.4. Pre-Sequencing
    • 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Sequencing
    • 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.6. Data Analysis
    • 6.6.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Whole Genome Sequencing Market: Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Whole Genome Sequencing Market: Application Movement Analysis
  • 7.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Human Whole Genome Sequencing
    • 7.4.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.5. Plant Whole Exome Sequencing
    • 7.5.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6. Animal Whole Exome Sequencing
    • 7.6.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.7. Microbial Whole Exome Sequencing
    • 7.7.1. Microbial Market, 2018 - 2030 (USD Million)

Chapter 8. Whole Genome Sequencing Market: End Use Business Analysis

  • 8.1. End use Segment Dashboard
  • 8.2. Global Whole Genome Sequencing Market: End use Movement Analysis
  • 8.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. UK Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Reimbursement Scenario
      • 9.4.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Reimbursement Scenario
      • 9.5.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. Reimbursement Scenario
      • 9.5.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. Reimbursement Scenario
      • 9.7.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Reimbursement Scenario
      • 9.7.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. Reimbursement Scenario
      • 9.7.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Reimbursement Scenario
      • 9.7.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Participant's Overview
    • 10.4.1. Illumina, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product & Service Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product & Service Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Oxford Nanopore Technologies
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product & Service Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Pacific Biosciences of California, Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product & Service Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. BGI
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product & Service Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. QIAGEN
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product & Service Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product & Service Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product & Service Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Psomagen
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product & Service Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Azenta US, Inc. (GENEWIZ)
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product & Service Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 28 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 29 Mexico whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 32 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 33 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 35 Europe whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 UK whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 UK whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 UK whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 UK whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 43 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Germany whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 47 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 48 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 50 France whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 52 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Italy whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 57 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Spain whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 68 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Sweden whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 75 Norway whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 84 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 89 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 China whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 93 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 94 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 96 India whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 98 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 99 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 101 Australia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 103 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 106 Thailand whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 108 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 109 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Korea whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 114 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 117 Latin America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 119 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 120 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 122 Brazil whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products/services
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Whole genome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Whole genome sequencing market: Porter's analysis
  • Fig. 15 Whole genome sequencing market: PESTLE analysis
  • Fig. 16 Whole genome sequencing market: Product & service outlook and key takeaways
  • Fig. 17 Whole genome sequencing market: Product & service movement analysis, 2024 - 2030
  • Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 19 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 20 Global services market, 2018 - 2030 (USD Million)
  • Fig. 21 Whole genome sequencing market: Type outlook and key takeaways
  • Fig. 22 Whole genome sequencing market: Type movement analysis, 2024 - 2030
  • Fig. 23 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 24 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 25 Whole genome sequencing market: Workflow outlook and key takeaways
  • Fig. 26 Whole genome sequencing market: Workflow movement analysis, 2024 - 2030
  • Fig. 27 Global pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 28 Global sequencing market, 2018 - 2030 (USD Million)
  • Fig. 29 Global data analysis market, 2018 - 2030 (USD Million)
  • Fig. 30 Whole genome sequencing market: Application outlook and key takeaways
  • Fig. 31 Whole genome sequencing market: Application movement analysis, 2024 - 2030
  • Fig. 32 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 33 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 34 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 35 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Whole genome sequencing market: End use outlook and key takeaways
  • Fig. 37 Whole genome sequencing market: End use movement analysis, 2024 - 2030
  • Fig. 38 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 39 Global hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 40 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 41 Global others market, 2018 - 2030 (USD Million)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Canada key country dynamics
  • Fig. 47 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico key country dynamics
  • Fig. 49 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 UK key country dynamics
  • Fig. 52 UK whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany key country dynamics
  • Fig. 54 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 France key country dynamics
  • Fig. 56 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Italy key country dynamics
  • Fig. 58 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Spain key country dynamics
  • Fig. 60 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark key country dynamics
  • Fig. 62 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden key country dynamics
  • Fig. 64 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Norway key country dynamics
  • Fig. 66 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 India key country dynamics
  • Fig. 73 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil key country dynamics
  • Fig. 82 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Argentina key country dynamics
  • Fig. 84 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa key country dynamics
  • Fig. 87 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia key country dynamics
  • Fig. 89 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 UAE key country dynamics
  • Fig. 91 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait key country dynamics
  • Fig. 93 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key company categorization
  • Fig. 95 Company market position analysis, 2024
  • Fig. 96 Market participant categorization
  • Fig. 97 Strategy framework